Top Story

HbA1c, diabetic retinopathy relationship supports cut-point diagnosis in Asians

November 24, 2014

The use of HbA1c levels to diagnose diabetes is appropriate among Asian populations, according to research published in The Journal of Clinical Endocrinology & Metabolism.

A 6.5% cut point performed reasonably well in analyses of major Asian ethnic groups, despite variation in the relationship between HbA1c and diabetic retinopathy, according to researchers.

Houston first US city to join Cities Changing Diabetes program

November 23, 2014
A partnership was recently announced between the city of Houston and Novo Nordisk to fight the urban diabetes epidemic, according to a company press release. The Cities…

First US bariatric embolization procedure performed

November 22, 2014
The first US bariatric embolization was recently performed by physicians at Dayton Interventional Radiology, according to a press release from the institution.The…
In the Journals

Lung transplant increased risk for dysglycemia, new-onset diabetes

November 21, 2014
In the first year after undergoing a lung transplant, most patients experience dysglycemia and may also be at significant risk for new-onset diabetes, according to…
Meeting News Coverage

BMI cited as poor predictor of early complications after TJA

November 21, 2014
DALLAS — Results of a database review study presented here indicated a correlation between increased body mass index and 30-day complications for total joint…
More News Headlines »
CME
Screening and Treatment of Diabetes-Associated Eye Disease

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
CME
Treatment of Acromegaly: Current Options - Part 3 of 5

Treatment of Acromegaly: Current Options - Part 3 of 5

This activity is supported by an educational grant from Genentech.

The goals of treatment for patients with acromegaly include controlling growth hormone excess, and relieving signs and…
More »
morganatic-roan
morganatic-roan